Hospital
Frick Hospital
Frick Hospital was paid $5.60M by Medicaid between Jan 2018 and Dec 2024, across 205 billing codes. Its largest line is 99285, emergency room visit (most serious) — 23% of everything it billed.
33Billing provider infoFRICK HOSPITAL
MT PLEASANT, PA 15666
MT PLEASANT, PA 15666
33aNPI1144255159assigned 07/11/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.60M
24GClaims210,394
24DCodes billed205
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#52 of 154
Median peer was paid$2.82M
This provider vs. median2.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 126 | $2K | |
| 2019 | 270 | $6K | |
| 2020 | 14,834 | $250K | |
| 2021 | 84,391 | $1.93M | |
| 2022 | 42,121 | $1.16M | |
| 2023 | 42,563 | $1.30M | |
| 2024incomplete | 26,089 | $941K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 8,600 | 8,360 | $1.29M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 10,184 | 9,894 | $1.10M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 10,864 | 10,629 | $795K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 1,379 | 1,355 | $237K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 5,796 | 5,603 | $156K |
| D7140 | Extraction, erupted tooth or exposed root | 2.7% | 384 | 383 | $150K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.9% | 13,104 | 12,319 | $104K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 19,573 | 17,845 | $92K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 1,125 | 1,098 | $73K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.2% | 1,958 | 1,940 | $65K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 3,581 | 3,382 | $64K |
| 87428 | <1% | 2,048 | 2,027 | $56K |
193 more codes
| 80061 | Lipid panel | <1% | 4,236 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 908 | $54K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,408 | $52K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,453 | $51K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 1,222 | $50K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,073 | $47K |
| 80053 | Comprehensive metabolic panel | <1% | 5,433 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,508 | $47K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,503 | $46K |
| 80050 | General health panel | <1% | 926 | $46K |
| G0378 | Hospital observation service, per hour | <1% | 61 | $45K |
| 80076 | <1% | 5,187 | $42K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,191 | $42K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,220 | $38K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,197 | $36K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 364 | $30K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 190 | $30K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 110 | $27K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 777 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 329 | $26K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 326 | $25K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 323 | $24K |
| 81001 | <1% | 8,660 | $23K | |
| 84484 | <1% | 2,665 | $22K | |
| 83690 | <1% | 4,569 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,372 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,489 | $19K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 238 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,473 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 226 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,169 | $14K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 138 | $13K |
| 71250 | <1% | 213 | $12K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 96 | $11K |
| 93971 | <1% | 170 | $11K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 288 | $10K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 44 | $10K |
| 87081 | <1% | 1,684 | $10K | |
| 85027 | <1% | 1,275 | $9K | |
| 82607 | <1% | 705 | $8K | |
| 82043 | <1% | 955 | $8K | |
| 84466 | <1% | 463 | $8K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 757 | $7K |
| 86618 | <1% | 309 | $7K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 129 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 446 | $7K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 326 | $7K |
| 71271 | <1% | 88 | $6K | |
| 76536 | <1% | 138 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,889 | $6K |
| 83735 | <1% | 893 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 24 | $5K |
| 84702 | <1% | 318 | $5K | |
| 82728 | <1% | 456 | $5K | |
| 85730 | <1% | 1,007 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 88 | $5K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 457 | $5K |
| 84153 | <1% | 195 | $5K | |
| 85610 | <1% | 1,744 | $5K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 29 | $5K |
| 84439 | <1% | 582 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 245 | $5K |
| 93017 | <1% | 138 | $4K | |
| 86803 | <1% | 220 | $4K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 364 | $4K |
| 76775 | <1% | 100 | $4K | |
| 73610 | <1% | 235 | $4K | |
| 73564 | <1% | 196 | $4K | |
| 83540 | <1% | 483 | $4K | |
| 74018 | <1% | 291 | $4K | |
| 87040 | <1% | 397 | $4K | |
| 87186 | <1% | 464 | $3K | |
| 73630 | <1% | 323 | $3K | |
| 82570 | <1% | 467 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,771 | $3K |
| 72141 | <1% | 15 | $3K | |
| 73030 | <1% | 207 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 63 | $3K |
| 86038 | <1% | 171 | $3K | |
| 97162 | <1% | 54 | $2K | |
| 97597 | <1% | 172 | $2K | |
| 74019 | <1% | 145 | $2K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,311 | $2K |
| 72100 | <1% | 112 | $2K | |
| 88342 | <1% | 56 | $2K | |
| 0002A | <1% | 70 | $2K | |
| 87077 | <1% | 280 | $2K | |
| 73130 | <1% | 183 | $2K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 13 | $2K |
| 85379 | <1% | 196 | $2K | |
| 85652 | <1% | 628 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 46 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 76 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 76 | $2K |
| 86140 | <1% | 575 | $2K | |
| 86617 | <1% | 35 | $2K | |
| 82746 | <1% | 128 | $1K | |
| 86255 | <1% | 66 | $1K | |
| 72110 | <1% | 81 | $1K | |
| 96376 | <1% | 238 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 183 | $1K |
| 0001A | <1% | 74 | $1K | |
| 80081 | <1% | 13 | $1K | |
| 87070 | <1% | 194 | $1K | |
| 72084 | <1% | 27 | $1K | |
| 86850 | <1% | 165 | $1K | |
| 86762 | <1% | 71 | $1K | |
| 83655 | <1% | 85 | $947.00 | |
| 73502 | <1% | 56 | $928.32 | |
| 82784 | <1% | 54 | $841.02 | |
| 86592 | <1% | 202 | $832.96 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 15 | $819.80 |
| 83605 | <1% | 125 | $806.39 | |
| 82950 | <1% | 119 | $806.08 | |
| 84403 | <1% | 29 | $788.40 | |
| 86787 | <1% | 39 | $777.84 | |
| 84481 | <1% | 37 | $742.35 | |
| 87088 | <1% | 119 | $741.28 | |
| 73110 | <1% | 63 | $726.58 | |
| 82565 | <1% | 117 | $720.32 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 45 | $687.67 |
| 29125 | <1% | 26 | $672.88 | |
| 85014 | <1% | 206 | $661.30 | |
| 85018 | <1% | 206 | $660.84 | |
| 84550 | <1% | 117 | $653.15 | |
| 84146 | <1% | 27 | $651.84 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $609.21 |
| 82948 | <1% | 644 | $569.57 | |
| 82550 | <1% | 92 | $568.59 | |
| 86431 | <1% | 70 | $524.06 | |
| 83880 | <1% | 28 | $515.59 | |
| 84520 | <1% | 96 | $515.31 | |
| 87147 | <1% | 140 | $500.04 | |
| 81025 | <1% | 136 | $449.68 | |
| 86901 | <1% | 153 | $448.72 | |
| 86900 | <1% | 153 | $447.12 | |
| A9270 | Non-covered item or service | <1% | 679 | $429.54 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $427.43 |
| 87505 | <1% | 13 | $419.55 | |
| 36591 | <1% | 263 | $387.10 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 4,342 | $383.93 |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | <1% | 193 | $376.95 |
| 83615 | <1% | 61 | $332.93 | |
| 84436 | <1% | 41 | $332.50 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 636 | $303.29 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,608 | $301.96 |
| 94729 | <1% | 13 | $299.36 | |
| 84100 | <1% | 76 | $288.54 | |
| 80055 | <1% | 60 | $276.24 | |
| 94726 | <1% | 14 | $273.94 | |
| 73590 | <1% | 19 | $261.36 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,049 | $246.04 |
| 83516 | <1% | 85 | $243.57 | |
| 94060 | <1% | 26 | $240.06 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,243 | $194.02 |
| 87340 | <1% | 12 | $190.79 | |
| J3490 | Unclassified drugs | <1% | 1,359 | $189.42 |
| 97161 | <1% | 17 | $156.63 | |
| 73080 | <1% | 14 | $155.94 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,879 | $155.20 |
| 73562 | <1% | 12 | $147.84 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $132.08 |
| 84460 | <1% | 24 | $128.42 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 737 | $126.78 |
| 97010 | <1% | 43 | $103.19 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 191 | $85.96 |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 199 | $81.10 |
| 87328 | <1% | 13 | $67.05 | |
| 87205 | <1% | 24 | $66.51 | |
| 96523 | <1% | 26 | $49.52 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 178 | $44.42 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 122 | $42.93 |
| 82140 | <1% | 14 | $39.46 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 100 | $39.19 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 155 | $35.71 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 45 | $28.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 455 | $26.95 |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 69 | $26.33 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,058 | $2.90 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,012 | $0.74 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 221 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 77 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 56 | $0.00 |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 37 | $0.00 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | 0% | 15 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 15 | $0.00 |
| 90715 | 0% | 15 | $0.00 | |
| 3044F | 0% | 241 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 539 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 924 | $0.00 |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 27 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 52 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCURRY, JEFFREY (EXECUTIVE VICE PRESIDENT CEO)
| Provider | Location | Paid |
|---|---|---|
| Westmoreland Hospital Association | Greensburg, PA | $6.79M |
| Latrobe Area Hospital, INC. | Latrobe, PA | $4.86M |
| Westmoreland Regional Hospital | Greensburg, PA | $3.06M |
| Latrobe Area Hospital | Latrobe, PA | $2.96M |
| Frick Hospital | Mt Pleasant, PA | $228K |
| Westmoreland Regional Hospital | Greensburg, PA | $34K |
| Westmoreland Regional Hospital | North Huntington, PA | $1K |
| Westmoreland Regional Hospital | Greensboro, PA | $35.05 |
| Latrobe Area Hospital | Latrobe, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.